Skip to content
10-Q

Quarterly Report

KINDRED BIOSCIENCES, INC.

0001561743-21-000036

← back to feed
Filed
May 11, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Apr 30, 2021 45.27M sh
Capex Q1 2021 · Mar 31, 2021 $260K
Capex Q1 2021 · Mar 31, 2020 $1.42M
Operating Cash Flow Q1 2021 · Mar 31, 2021 −$9.41M
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$17.11M
Long Term Debt Q1 2021 · Mar 31, 2021 $20.76M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $12.91M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $11.62M
Stockholders Equity Q1 2021 · Mar 31, 2021 $83.79M
Stockholders Equity Q1 2021 · Dec 31, 2020 $67.48M
Stockholders Equity Q1 2021 · Mar 31, 2020 $60.67M
Stockholders Equity Q1 2021 · Dec 31, 2019 $81.92M
Current Liabilities Q1 2021 · Mar 31, 2021 $6.55M
Current Liabilities Q1 2021 · Dec 31, 2020 $6.9M
Total Liabilities Q1 2021 · Mar 31, 2021 $26.19M
Total Liabilities Q1 2021 · Dec 31, 2020 $28.33M
Current Assets Q1 2021 · Mar 31, 2021 $79.09M
Current Assets Q1 2021 · Dec 31, 2020 $62.62M
Total Assets Q1 2021 · Mar 31, 2021 $109.98M
Total Assets Q1 2021 · Dec 31, 2020 $95.81M
Rd Expense Q1 2021 · Mar 31, 2021 $6.29M
Rd Expense Q1 2021 · Mar 31, 2020 $8.87M
Net Income Q1 2021 · Mar 31, 2021 −$9.74M
Net Income Q1 2021 · Mar 31, 2020 −$22.76M
Operating Income Q1 2021 · Mar 31, 2021 −$9.17M
Operating Income Q1 2021 · Mar 31, 2020 −$22.39M
Gross Profit Q1 2021 · Mar 31, 2021 $1.81M
Gross Profit Q1 2021 · Mar 31, 2020 −$2.97M
Cost Of Revenue Q1 2021 · Mar 31, 2021 $590K
Cost Of Revenue Q1 2021 · Mar 31, 2020 $3.58M
Revenue Q1 2021 · Mar 31, 2021 $2.4M
Revenue Q1 2021 · Mar 31, 2020 $603K